186 related articles for article (PubMed ID: 12385921)
1. Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism.
Veltri RW; Marks LS; Miller MC; Bales WD; Fan J; Macairan ML; Epstein JI; Partin AW
Urology; 2002 Oct; 60(4):617-22. PubMed ID: 12385921
[TBL] [Abstract][Full Text] [Related]
2. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens.
Marks LS; Hess DL; Dorey FJ; Luz Macairan M; Cruz Santos PB; Tyler VE
Urology; 2001 May; 57(5):999-1005. PubMed ID: 11337315
[TBL] [Abstract][Full Text] [Related]
3. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia.
Marks LS; Partin AW; Epstein JI; Tyler VE; Simon I; Macairan ML; Chan TL; Dorey FJ; Garris JB; Veltri RW; Santos PB; Stonebrook KA; deKernion JB
J Urol; 2000 May; 163(5):1451-6. PubMed ID: 10751856
[TBL] [Abstract][Full Text] [Related]
4. Saw palmetto for benign prostatic hyperplasia.
Bent S; Kane C; Shinohara K; Neuhaus J; Hudes ES; Goldberg H; Avins AL
N Engl J Med; 2006 Feb; 354(6):557-66. PubMed ID: 16467543
[TBL] [Abstract][Full Text] [Related]
5. The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial.
Andriole GL; McCullum-Hill C; Sandhu GS; Crawford ED; Barry MJ; Cantor A;
J Urol; 2013 Feb; 189(2):486-92. PubMed ID: 23253958
[TBL] [Abstract][Full Text] [Related]
6. Benign prostatic hyperplasia treated with saw palmetto: a literature search and an experimental case study.
McPartland JM; Pruitt PL
J Am Osteopath Assoc; 2000 Feb; 100(2):89-96. PubMed ID: 10732392
[TBL] [Abstract][Full Text] [Related]
7. Saw palmetto for the treatment of men with lower urinary tract symptoms.
Gerber GS
J Urol; 2000 May; 163(5):1408-12. PubMed ID: 10751846
[TBL] [Abstract][Full Text] [Related]
8. Saw palmetto and benign prostatic hyperplasia.
Gong EM; Gerber GS
Am J Chin Med; 2004; 32(3):331-8. PubMed ID: 15344416
[TBL] [Abstract][Full Text] [Related]
9. Serenoa repens for benign prostatic hyperplasia.
Wilt T; Ishani A; Mac Donald R
Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
[TBL] [Abstract][Full Text] [Related]
10. Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats.
Arruzazabala ML; Más R; Molina V; Noa M; Carbajal D; Mendoza N
Drugs R D; 2006; 7(4):233-41. PubMed ID: 16784248
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms.
Gerber GS; Kuznetsov D; Johnson BC; Burstein JD
Urology; 2001 Dec; 58(6):960-4; discussion 964-5. PubMed ID: 11744467
[TBL] [Abstract][Full Text] [Related]
12. A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency.
Sudeep HV; Thomas JV; Shyamprasad K
BMC Urol; 2020 Jul; 20(1):86. PubMed ID: 32620155
[TBL] [Abstract][Full Text] [Related]
13. Phytotherapy for benign prostatic hyperplasia.
Gerber GS
Curr Urol Rep; 2002 Aug; 3(4):285-91. PubMed ID: 12149159
[TBL] [Abstract][Full Text] [Related]
14. Serenoa repens (Permixon): a 5alpha-reductase types I and II inhibitor-new evidence in a coculture model of BPH.
Bayne CW; Donnelly F; Ross M; Habib FK
Prostate; 1999 Sep; 40(4):232-41. PubMed ID: 10420151
[TBL] [Abstract][Full Text] [Related]
15. Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.
Willetts KE; Clements MS; Champion S; Ehsman S; Eden JA
BJU Int; 2003 Aug; 92(3):267-70. PubMed ID: 12887481
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
Debruyne F; Koch G; Boyle P; Da Silva FC; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP
Eur Urol; 2002 May; 41(5):497-506; discussion 506-7. PubMed ID: 12074791
[TBL] [Abstract][Full Text] [Related]
17. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.
Plosker GL; Brogden RN
Drugs Aging; 1996 Nov; 9(5):379-95. PubMed ID: 8922564
[TBL] [Abstract][Full Text] [Related]
18. Saw palmetto for prostate disorders.
Gordon AE; Shaughnessy AF
Am Fam Physician; 2003 Mar; 67(6):1281-3. PubMed ID: 12674456
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.
Di Silverio F; Monti S; Sciarra A; Varasano PA; Martini C; Lanzara S; D'Eramo G; Di Nicola S; Toscano V
Prostate; 1998 Oct; 37(2):77-83. PubMed ID: 9759701
[TBL] [Abstract][Full Text] [Related]
20. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.
Barry MJ; Meleth S; Lee JY; Kreder KJ; Avins AL; Nickel JC; Roehrborn CG; Crawford ED; Foster HE; Kaplan SA; McCullough A; Andriole GL; Naslund MJ; Williams OD; Kusek JW; Meyers CM; Betz JM; Cantor A; McVary KT;
JAMA; 2011 Sep; 306(12):1344-51. PubMed ID: 21954478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
